HUMAN MONOCLONAL-ANTIBODY DETECTS A CELL-SURFACE ANTIGEN EXPRESSED ON HEMATOPOIETIC MALIGNANT-CELLS OF LYMPHOID LINEAGE

被引:2
作者
IIZASA, T
YAMAGUCHI, Y
TAGAWA, M
FUJISAWA, T
SAITO, H
KONDO, H
MATSUO, Y
MINOWADA, J
TANIGUCHI, M
机构
[1] CHIBA UNIV,SCH MED,INST PULM CANC RES,DEPT SURG,CHIBA 280,JAPAN
[2] CHIBA UNIV,SCH MED,DEPT MED,CHIBA 280,JAPAN
[3] HAYASHIBARA BIOCHEM LAB INC,FUJISAKI CELL CTR,OKAYAMA 702,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1991年 / 82卷 / 02期
关键词
HUMAN MONOCLONAL ANTIBODY; CML; BLAST CRISIS; LINEAGE MARKER;
D O I
10.1111/j.1349-7006.1991.tb01831.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An antigen with a molecular weight of 150 kilodaltons expressed on certain leukemia and lymphoma cells was recognized by a human monoclonal antibody (3H12), which had been established by the fusion of lymphocytes from a small cell lung cancer patient with a mouse myeloma cell line (P3U1). Peripheral blood mononuclear cells from 3 out of 4 cases with lymphoid crisis of chronic myelogenous leukemia (CML) were positively stained by 3H12, while cells from 5 cases with myeloid crisis of CML did not react to this antibody. The antibody did not show any reactivity to cells from the chronic phase of CML, other types of leukemias or normal hematopoietic cells. We further examined 29 cell lines of hematopoietic origin and found that 2 undifferentiated cells (BV-173 and K-562) reacted to the 3H12 antibody. In addition, we found that 3 out of 6 Burkitt lymphoma cells (DAUDI, RAJI and HR1K) reacted to 3H12. Taken together, these results suggest that the antigen recognized by 3H12 is a differentiation-associated antigen expressed on immature lymphoid cells and could potentially be a reliable cell lineage marker.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 24 条
[1]  
BALL ED, 1987, CANCER RES, V47, P6556
[2]  
BUNN PA, 1985, BLOOD, V65, P764
[3]   ESTABLISHMENT OF HUMAN MONOCLONAL-ANTIBODY RECOGNIZING A NEW TUMOR-ASSOCIATED ANTIGEN FROM A PATIENT WITH SMALL-CELL LUNG-CARCINOMA [J].
IIZASA, T ;
YAMAGUCHI, Y ;
TAGAWA, M ;
SAITO, H ;
FUJISAWA, T ;
KATO, K ;
TANIGUCHI, M .
HYBRIDOMA, 1990, 9 (03) :211-219
[4]  
JANOSSY G, 1979, CANCER, V43, P426, DOI 10.1002/1097-0142(197902)43:2<426::AID-CNCR2820430204>3.0.CO
[5]  
2-H
[6]   CHARACTERISTICS OF TERMINAL PHASE OF CHRONIC GRANULOCYTIC LEUKEMIA [J].
KARANAS, A ;
SILVER, RT .
BLOOD, 1968, 32 (03) :445-&
[7]   AN EPSTEIN-BARR VIRUS IMMEDIATE-EARLY GENE-PRODUCT TRANS-ACTIVATES GENE-EXPRESSION FROM THE HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT [J].
KENNEY, S ;
KAMINE, J ;
MARKOVITZ, D ;
FENRICK, R ;
PAGANO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1652-1656
[8]  
KNAPP W, 1989, BLOOD, V74, P1448
[9]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[10]  
LEBIEN TW, 1982, J IMMUNOL, V129, P2287